drugset / Trial / NCT00347438
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
Phase 2
Terminated
18 enrolled
University of Chicago
Breast Cancer Research Foundation · collabRoche Pharma AG · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and effectiveness of capecitabine before surgery. The study will also help gain more information about the effects of the capecitabine on physical and emotional well-being and how well the participants on capecitabine follow the study drug plan.
Timeline
- Start
- 2006-09
- Primary completion
- 2013-03
- Completion
- 2013-03
Outcome
Outcome not reported
Stopped (Enrollment): “a result of slow accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | — |